Deverra Therapeutics Alternatives & Competitors
12 companies similar to Deverra Therapeutics — Cell Therapies for All
Companies similar to Deverra Therapeutics
Celularity Inc.
A next-gen Biotech company creating off-the-shelf cellular medicines for Cancer, Infectiou...
United States
AlloVir
A global leader in allogeneic, off-the-shelf, multi-virus specific T- cell immunotherapies...
Waltham, United States
SQZ Biotechnologies
Unlocking the full potential of cell therapies for patients around the world
Watertown, United States
Cartesian Therapeutics
Cartesian | Developing potent, safer cell and gene therapies for cancer and autoimmune dis...
Track all Deverra Therapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Progenitor Life Sciences, LLC
Harnessing advanced technology to generate pluripotent stem cells for innovative immune ce...
Salt Lake City, United St...
NexImmune, Inc.
NexImmune, Directing T cell function to restore natural immunity
Gaithersburg, United Stat...
Prescient Therapeutics
A clinical stage oncology company developing personalised medicine approaches to cancer; c...
Australia
ImmunoCellular Therapeutics Ltd
Pioneering immune-based therapies to harness the body's defenses against cancer through ad...
Calabasas, United States
Artiva Biotherapeutics
We are dedicated to making safe and effective cell therapies accessible to any cancer pati...
San Diego, United States
Century Therapeutics, Inc
Advancing iPSC-derived cell therapies to transform care in autoimmune disease and cancer
Philadelphia, United Stat...
Cell BioEngines, Inc
‘Off-the-Shelf’ Curative Cell Therapies
New York, United States
About Deverra Therapeutics
Deverra Therapeutics is a biotechnology startup founded in 2019 with a primary focus on developing allogeneic, off-the-shelf cellular immunotherapies for on-demand treatment of patients with cancer and infectious diseases. The company holds an exclusive license to a proprietary stem cell expansion and directed-differen...
Cell Therapies, Clinical Stage, Allogeneic Cellular Immunotherapies, Stem Cell Expansion, Directed Differentiation Platform, Cancer Treatment, Infectious Diseases Treatment, Proprietary Technology, Clinical Trials, Immunotherapy, Fred Hutchinson Cancer Research Center, Immune Cell Therapy, Therapeutic Development, Patient-centric Treatment
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Deverra Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Deverra Therapeutics on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
